The value of using ambroxol hydrochloride in the treatment of elderly pneumonia
老年肺炎治疗中应用盐酸氨溴索的价值研究

摘要

目的 探讨在老年肺炎患者临床治疗中应用盐酸氨溴索的效果和应用价值。方法 选取2022年7月~2023年7月于我院进行治疗的老年肺炎患者60例，按其治疗方式分为对照组（常规治疗）和观察组（盐酸氨溴索治疗）各30例，对比两组临床疗效。结果 治疗前两组氧合指数和D-二聚体指数差异无统计学意义（P＜0.05）。治疗后观察组患者氧合指数、肺功能指标均高于对照组，D-二聚体、炎症因子水平指标低于对照组，且观察组治疗时间和临床症状消失时间均短于对照组，差异均有统计学意义（P＜0.05）。结论 盐酸氨溴索对老年肺炎患者具有应用价值，能够帮助患者改善氧合、D-D和肺功能情况，降低炎症，加快临床症状消失，促进恢复。

Abstract

Objective To explore the efficacy and value of using ambroxol hydrochloride in the clinical treatment of elderly pneumonia patients.
Methods Sixty elderly patients with pneumonia who underwent treatment in a hospital from July 2022 to July 2023 were selected and divided into a control group (conventional treatment) and an observation group (ambroxol hydrochloride treatment), with 30 cases in each group, according to their treatment methods. The clinical efficacy of the two groups was compared.
Results There was no statistically significant difference in oxygenation index and D-dimer index between the two groups before treatment (P<0.05). After treatment, the oxygenation index and lung function indicators of the observation group were higher than those of the control group, while the levels of D-dimer and inflammatory factors were lower than those of the control group. In addition, the treatment time and clinical symptom disappearance time of the observation group were shorter than those of the control group, and the differences were statistically significant (P<0.05).
Conclusion   Ambroxol hydrochloride has application value in elderly patients with pneumonia, which can help improve oxygenation, D-D, and lung function, reduce inflammation, accelerate clinical symptom disappearance, and promote recovery.